This inventor holds 1 USPTO granted patent. Top assignee: Roche Glycart Ag. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Maud Léa Mayoux: Inventor in Antibody Research
Introduction
Maud Léa Mayoux is an inventor based in Zürich, Switzerland. Her patent work includes an invention concerning antibodies that bind to GPRC5D, a target studied in biomedical research.
Latest Patents
Mayoux is listed as an inventor on 1 patent: “Antibodies Binding to GPRC5D.” The patent concerns antibodies that bind to the GPRC5D protein.
Career Highlights
Mayoux is associated with Roche Glycart AG, a biotechnology company. Her listed patent reflects work in antibody research and therapeutic development.
Collaborations
The patent record also names Alexander Bujotzek and Tony Christopeit as collaborators.
Conclusion
Maud Léa Mayoux’s recorded invention focuses on antibodies binding to GPRC5D and reflects her connection to Roche Glycart AG and collaborative biotechnology research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile